Increased bioactive lipids content in human subcutaneous and epicardial fat tissue correlates with insulin resistance

Lipids

Volumn 47, Issue 12, 2012, Pages 1131-1141

  Błachnio Zabielska, Agnieszka U ^a   Baranowski, Marcin ^a   Hirnle, Tomasz ^a   Zabielski, Piotr ^a   Lewczuk, Anna ^a   Dmitruk, Iwona ^a   Górski, Jan ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Ceramide; Diabetes; Diacylglycerols; Long chain acyl CoA; Obesity

Indexed keywords

ACYL COENZYME A; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; MYRISTIC ACID; PALMITOLEIC ACID; SPHINGOLIPID; SULFONYLUREA; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC OBESITY; ELECTROSPRAY; EPICARDIAL FAT TISSUE; FATTY ACID ANALYSIS; FEMALE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; LIQUID CHROMATOGRAPHY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SUBCUTANEOUS FAT; TANDEM MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

AGED; CHOLESTEROL; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; OBESITY; PERICARDIUM; SUBCUTANEOUS FAT; TANDEM MASS SPECTROMETRY;

EID: 84872263484     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-012-3722-x     Document Type: Article

References (49)

1. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM (1999) Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 17:555-560
2. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746-26749
3. Winkler G, Kiss S, Keszthelyi L, Sápi Z, Ory I, Salamon F, Kovács M, Vargha P, Szekeres O, Speer G et al (2003) Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol 149:129-135
4. Kannel WB (1985) Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J 110:1100-1107
5. Larsson B (1991) Obesity, fat distribution and cardiovascular disease. Int J Obes 15(Suppl 2):53-57
6. Iacobellis G, Sharma AM (2007) Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr Pharm Des 13:2180-2184
7. Iacobellis G, Ribaudo MC, Leto G, Zappaterreno A, Vecci E, Di Mario U, Leonetti F (2002) Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res 10:767-773
8. Iacobellis G, Sharma AM (2007) Obesity and the heart: redefinition of the relationship. Obes Rev 8:35-39
9. Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21: 697-738
10. Tzanavari T, Giannogonas P, Karalis KP (2010) TNF-alpha and obesity. Curr Dir Autoimmun 11:145-156
11. Trayhurn P, Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347-355
12. Prins JB (2002) Adipose tissue as an endocrine organ. Best Pract Res Clin Endocrinol Metab 16:639-651
13. Owecki M (2009) Fat tissue and adiponectin: new players in critical care? Crit Care 13:174
14. Gormez S, Demirkan A, Atalar F, Caynak B, Erdim R, Sozer V, Gunay D, Akpinar B, Ozbek U, Buyukdevrim AS (2011) Adipose tissue gene expression of adiponectin, tumor necrosis factor - a and leptin in metabolic syndrome patients with coronary artery disease. Intern Med 50:805-810
15. Ahima RS (2006) Adipose tissue as an endocrine organ. Obesity (Silver Spring) 14(Suppl 5):242S-249S
16. Marchington JM, Mattacks CA, Pond CM (1989) Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B 94:225-232
17. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ et al (2002) Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:50230-50236
18. Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176
19. Shah C, Yang G, Lee I, Bielawski J, Hannun YA, Samad F (2008) Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem 283:13538-13548
20. Summers SA (2006) Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45:42-72
21. Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, Summers SA (2007) Lipid mediators of insulin resistance. Nutr Rev 65:S39-S46
22. Augé N, Maupas-Schwalm F, Elbaz M, Thiers JC, Waysbort A, Itohara S, Krell HW, Salvayre R, Nègre-Salvayre A (2004) Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 110:571-578
23. Augé N, Nègre-Salvayre A, Salvayre R, Levade T (2000) Sphingomyelin metabolites in vascular cell signaling and atherogenesis. Prog Lipid Res 39:207-229
24. Hojjati MR, Li Z, Zhou H, Tang S, Huan C, Ooi E, Lu S, Jiang XC (2005) Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice. J Biol Chem 280: 10284-10289
25. Kolak M, Westerbacka J, Velagapudi VR, Wågsäter D, Yetukuri L, Makkonen J, Rissanen A, Häkkinen AM, Lindell M, Bergholm R et al (2007) Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 56:1960-1968
26. Blachnio-Zabielska AU, Pulka M, Baranowski M, Nikolajuk A, Zabielski P, Gorska M, Gorski J (2012) Ceramide metabolism is affected by obesity and diabetes in human adipose tissue. J Cell Physiol 227:550-557
27. Blachnio-Zabielska AU, Koutsari C, Tchkonia T, Jensen MD (2012) Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance. Obesity. doi:10.1038/oby.2012.126
28. Long SD, Pekala PH (1996) Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. Biochem J 319(Pt 1):179-184
29. Jornayvaz FR, Shulman GI (2012) Diacylglycerol activation of protein kinase Ce and hepatic insulin resistance. Cell Metab 15: 574-584
30. Persson XM, Blachnio-Zabielska AU, Jensen MD (2010) Rapid measurement of plasma free fatty acid concentration and isotopic enrichment using LC/MS. J Lipid Res 51:2761-2765
31. Blachnio-Zabielska AU, Persson XM, Koutsari C, Zabielski P, Jensen MD (2012) A liquid chromatography/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular ceramides in humans. Rapid Commun Mass Spectrom 26:1134-1140
32. Blachnio-Zabielska AU, Koutsari C, Jensen MD (2011) Measuring long-chain acyl-coenzyme A concentrations and enrichment using liquid chromatography/tandem mass spectrometry with selected reaction monitoring. Rapid Commun Mass Spectrom 25:2223-2230
33. Straczkowski M, Kowalska I, Baranowski M, Nikolajuk A, Otziomek E, Zabielski P, Adamska A, Blachnio A, Gorski J, Gorska M (2007) Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 50: 2366-2373
34. Frangioudakis G, Garrard J, Raddatz K, Nadler JL, Mitchell TW, Schmitz-Peiffer C (2010) Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors. Endocrinology 151:4187-4196
35. Adams JM, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, Mandarino LJ (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53:25-31
36. Blachnio-Zabielska A, Baranowski M, Zabielski P, Gorski J (2010) Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle. J Cell Physiol 225:786-791
37. Blachnio-Zabielska A, Zabielski P, Baranowski M, Gorski J (2011) Aerobic training in rats increases skeletal muscle sphin-gomyelinase and serine palmitoyltransferase activity. While decreasing ceramidase activity. Lipids 46:229-238
38. Blachnio-Zabielska A, Zabielski P, Baranowski M, Gorski J (2010) Effects of streptozotocin-induced diabetes and elevation of plasma FFA on ceramide metabolism in rat skeletal muscle. Horm Metab Res 42:1-7
39. Blachnio-Zabielska A, Baranowski M, Zabielski P, Gorski J (2008) Effect of exercise duration on the key pathways of cera-mide metabolism in rat skeletal muscles. J Cell Biochem 105: 776-784
40. Stephens JM, Pekala PH (1992) Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis. J Biol Chem 267:13580-13584
41. Stephens JM, Pekala PH (1991) Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem 266:21839-21845
42. Aerts JM, Ottenhoff R, Powlson AS, Grefhorst A, van Eijk M, Dubbelhuis PF, Aten J, Kuipers F, Serlie MJ, Wennekes T et al (2007) Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity. Diabetes 56:1341-1349
43. Tchoukalova YD, Koutsari C, Votruba SB, Tchkonia T, Giorgadze N, Thomou T, Kirkland JL, Jensen MD (2010) Sex and depot-dependent differences in adipogenesis in normal-weight humans. Obesity (Silver Spring) 18:1875-1880
44. Tchoukalova YD, Votruba SB, Tchkonia T, Giorgadze N, Kirkland JL, Jensen MD (2010) Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci USA 107:18226-18231
45. Hannun YA, Obeid LM (2002) The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 277:25847-25850
46. Zheng W, Kollmeyer J, Symolon H, Momin A, Munter E, Wang E, Kelly S, Allegood JC, Liu Y, Peng Q et al (2006) Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta 1758: 1864-1884
47. Xi L, Qian Z, Xu G, Zhou C, Sun S (2007) Crocetin attenuates palmitate-induced insulin insensitivity and disordered tumor necrosis factor-alpha and adiponectin expression in rat adipocytes. Br J Pharmacol 151:610-617
48. Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, Still CD, Gerhard GS, Han X, Dziura J et al (2011) Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA 108:16381-16385
49. Erion DM, Shulman GI (2010) Diacylglycerol-mediated insulin resistance. Nat Med 16:400-402